FLT4 and breast cancer: In models of breast cancer, the release of norepinephrine induced by stress stimulates cancer cells to secrete VEGFC, which in turn fosters lymphangiogenesis, remodeling, and an increase in stromal expression of VEGFR3 (FLT4) (84).